Ömer Yavuz | Medicine and Health Sciences | Excellence in Research Award

Published on by Top Teachers

Excellence in Research Award

Ömer Yavuz
Başakşehir Çam and Sakura City Hospital, Turkey
Ömer Yavuz
Affiliation Başakşehir Çam and Sakura City Hospital
Country Turkey
Scopus ID 56712503200
Documents 11
Citations 44
h-index 4
Subject Area Medicine and Health Sciences
Event Top Teachers Awards

Ömer Yavuz is a thoracic surgery specialist affiliated with Başakşehir Çam and Sakura City Hospital. He has contributed significantly to thoracic surgery research through clinical investigations, minimally invasive surgical innovations, oncological studies, and multidisciplinary collaborations.[1] His academic profile reflects active participation in peer-reviewed publications, international scientific congresses, educational activities, and collaborative healthcare research initiatives within thoracic and pulmonary medicine. The Excellence in Research Award recognizes his distinguished scholarly achievement, sustained scientific contribution, and professional advancement in the field of medicine and health sciences.[2]

Abstract

Ömer Yavuz is a Turkish thoracic surgery specialist whose academic activities encompass clinical thoracic surgery, pulmonary oncology, minimally invasive surgical procedures, robotic thoracic surgery, and perioperative patient management. His scholarly contributions include peer-reviewed journal publications, conference presentations, collaborative multicenter studies, and educational involvement in thoracic surgery seminars.[3] His research portfolio demonstrates continuing engagement with contemporary surgical techniques and evidence-based clinical practice, particularly in lung cancer surgery, thoracic oncology, port catheter applications, and minimally invasive approaches.[4]

Keywords

Thoracic Surgery, Lung Cancer, Robotic Surgery, Pulmonary Oncology, Minimally Invasive Surgery, Thoracic Oncology, Video-Assisted Thoracoscopic Surgery, Surgical Research, Medical Education, Clinical Research.

Introduction

Thoracic surgery remains an essential subspecialty within medicine, requiring the integration of surgical precision, oncological knowledge, and multidisciplinary clinical coordination. Research in this field contributes to the advancement of minimally invasive interventions, perioperative management, and improved long-term patient outcomes. Within this context, Ömer Yavuz has participated in clinical and academic activities addressing thoracic surgical practice, lung cancer management, robotic-assisted procedures, and rare thoracic disorders.[5]

His professional training includes medical education at Gülhane Military Medical Faculty and specialization in thoracic surgery at Gülhane Military Medical Academy Haydarpaşa Training Hospital. Subsequent clinical appointments at Muş State Hospital, Koç University Hospital, and Başakşehir Çam and Sakura City Hospital contributed to the development of his clinical and academic profile.[6]

Research Profile

The research profile of Ömer Yavuz reflects interdisciplinary collaboration across thoracic surgery, oncology, pathology, and minimally invasive surgical technologies. His publications include clinical analyses, surgical case reports, retrospective investigations, translational research studies, and conference proceedings focused on thoracic diseases and operative outcomes.[7]

Research topics addressed in his work include pectus excavatum surgery, pleurodesis techniques, thoracic oncology, spread through air spaces in lung adenocarcinoma, immune profiling after minimally invasive lobectomy, robotic thoracic surgery, port catheter complications, and bibliometric analyses of surgical literature.[8]

In addition to publication activities, he has participated in national and international scientific congresses, including presentations associated with the World Conference on Lung Cancer, the European Society of Thoracic Surgeons, and Turkish thoracic surgery congresses.[9]

Research Contributions

Ömer Yavuz has contributed to research evaluating minimally invasive surgical procedures and thoracic oncological management. His collaborative study on immune profiling after minimally invasive lobectomy examined postoperative immunological responses following thoracic surgical intervention.[10]

Additional research contributions include investigations into thoracic surgical outcomes during the COVID-19 pandemic, demonstrating the feasibility of elective cancer surgery during periods of healthcare system restriction.[11] Other studies addressed prognostic indicators in lung adenocarcinoma, including spread through air spaces identified through PET/CT imaging modalities.[12]

His more recent research activities involve robotic-assisted thoracic surgery, landmark-based port catheter placement techniques, thoracic outlet syndrome procedures, and perioperative management strategies in low-resource surgical settings.[13] Several accepted publications scheduled for 2026 further demonstrate ongoing academic engagement in thoracic surgical innovation and healthcare research productivity.[14]

  • Research in minimally invasive thoracic surgery and robotic-assisted procedures.
  • Clinical investigations in lung cancer surgery and thoracic oncology.
  • Studies involving perioperative outcomes and surgical feasibility during the COVID-19 pandemic.
  • Development of port catheter placement approaches in resource-limited clinical settings.
  • Participation in multidisciplinary and international thoracic surgery collaborations.

Publications

Ömer Yavuz has contributed to thoracic surgery research through publications focused on minimally invasive surgery, thoracic oncology, robotic-assisted procedures, perioperative management, and pulmonary diseases. His scholarly work includes clinical investigations on lung adenocarcinoma, immune profiling after lobectomy, pleurodesis techniques, hyperhidrosis surgery outcomes, and port catheter complications. He has also participated in multidisciplinary and international collaborative studies published in peer-reviewed medical journals, including research related to COVID-19 surgical management and malignant pleural mesothelioma. These publications demonstrate sustained engagement with evidence-based thoracic surgery, innovative surgical methodologies, and contemporary clinical challenges within medicine and health sciences.

Research Impact

The academic contributions of Ömer Yavuz have supported ongoing discussions related to thoracic surgical techniques, perioperative care, robotic-assisted interventions, and oncological thoracic procedures. His Scopus-indexed publication record demonstrates measurable citation activity and participation in collaborative scientific research.[15]

His involvement in educational seminars and professional associations, including the Turkish Thoracic Society, Turkish Society of Thoracic Surgery, and European Society of Thoracic Surgeons, further reflects sustained engagement with academic medicine and surgical education.[16]

  • Peer-reviewed publications indexed in international academic databases.
  • Conference presentations at national and international thoracic surgery congresses.
  • Research participation in EU Framework Program and TÜBİTAK-supported scientific projects.
  • Ongoing publication activity in robotic thoracic surgery and surgical innovation.
  • Academic teaching contributions within thoracic surgery clinical seminars.

Award Suitability

The scholarly record of Ömer Yavuz demonstrates alignment with the objectives of the Excellence in Research Award presented through the Top Teachers Awards platform. His contributions to thoracic surgery research, publication activity in peer-reviewed journals, participation in international congresses, and involvement in educational and collaborative medical initiatives collectively support recognition for academic and professional achievement.[17]

Particular areas of distinction include minimally invasive thoracic surgery, robotic-assisted surgical techniques, thoracic oncology research, and clinical studies concerning perioperative outcomes and surgical methodologies in varying healthcare settings.[18]

Conclusion

Ömer Yavuz has established an academic and clinical profile characterized by ongoing participation in thoracic surgery research, scientific collaboration, and surgical education. His publication history, conference involvement, and clinical specialization reflect continued engagement with evidence-based thoracic surgical practice and medical research development. The breadth of his scholarly contributions within medicine and health sciences provides a substantial basis for recognition through the Excellence in Research Award.[19]

References

    1. Elsevier. (n.d.). Scopus author details: Ömer Yavuz, Author ID 56712503200. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56712503200
    2. Başakşehir Çam and Sakura City Hospital. (n.d.). Thoracic surgery and clinical research activities.
    3. Yıldızhan, A., Candaş, F. H., Yavuz, Ö., et al. (2015). Experiences with the Nuss Procedure in Young Adult Patients with Pectus Excavatum.DOI: https://doi.org/10.5606/tgkdc.dergisi.2015.10497
    4. Erus, S., Öztürk, A. B., Albayrak, Ö., et al. (2021). Immune Profiling After Minimally Invasive Lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    5. Marazioti, A., et al. (2021). KRAS Signaling in Malignant Pleural Mesothelioma. DOI: https://doi.org/10.15252/emmm.202013631
    6. Curriculum Vitae of Ömer Yavuz. (2026). Professional experience and academic background.
    7. Süer, H., et al. (2023). Combination of CEACAM5, EpCAM and CK19 Gene Expressions in Mediastinal Lymph Node Micrometastasis. DOI: https://doi.org/10.1186/s13019-023-02297-z
    8. Yavuz, Ö., İşcan, M. (2025). Port Catheter Thickness and Its Correlation with Complications – Exploring the Millimeter Threshold. DOI: https://doi.org/10.1186/s13019-025-03817-9
    9. European Society of Thoracic Surgeons. (2022). Conference proceedings and poster presentations.
    10. Interactive CardioVascular and Thoracic Surgery. (2021). Immune profiling after minimally invasive lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    11. Kulle, C. B., et al. (2021). Is Elective Cancer Surgery Feasible During the Lock-Down Period of the COVID-19 Pandemic? DOI: https://doi.org/10.1002/jso.26436
    12. Falay, O., et al. (2021). Prediction of Spread Through Air Spaces with Preoperative 18F-FDG PET/CT in Primary Lung Adenocarcinoma. DOI: https://doi.org/10.1097/MNM.0000000000001414
    13. İşcan, M., Yavuz, Ö. (2026). Uniportal Robotic-Assisted Thoracic Surgery for Anatomical Lung Resections. DOI: https://doi.org/10.20452/wiitm.2026.18021
    14. Current Thoracic Surgery. (2026). Accepted publications in thoracic surgery and bibliometric analysis.
    15. Scopus Database Metrics. (n.d.). Author citation indicators and publication statistics.
    16. Turkish Thoracic Society; Turkish Society of Thoracic Surgery; European Society of Thoracic Surgeons. (n.d.). Professional membership records.
    17. Top Teachers Awards. (n.d.). Excellence in Research Award recognition framework. https://topteachers.net/
    18. CTSNet. (2024–2025). Robotic thoracic surgery and port catheter publications.
    19. Academic Curriculum Documentation. (2026). Teaching activities, conference participation, and scholarly output.

Sebiha Demir | Health Sciences | Best Researcher Award

Published on by Top Teachers

Ms. Sebiha Demir | Health Sciences | Best Researcher Award

University Hospital Bonn | Germany

Ms. Sebiha Demir is a dedicated medical researcher specializing in neonatology, neonatal neuroprotection, and perinatal brain injury. Her research focuses on improving clinical outcomes for asphyxiated newborns through evidence-based innovations in therapeutic hypothermia and neurophysiological monitoring. She integrates advanced diagnostic tools such as amplitude-integrated electroencephalography (aEEG) and biochemical profiling to identify early predictors of hypoxic-ischemic encephalopathy (HIE), advancing precision medicine in neonatal intensive care. Her notable publication, “Abnormal Amplitude‐Integrated Electroencephalography and Acidosis as Key Criteria Initiating Therapeutic Hypothermia in Asphyxiated Newborns – Data From the German Hypothermia Registry” (Acta Paediatrica, 2025), demonstrates her significant contribution to establishing objective criteria for initiating life-saving interventions in high-risk neonates. Through collaborative research with multidisciplinary teams across Europe, Dr. Demir has enriched neonatal care protocols and contributed to shaping guidelines for early neurological assessment and treatment strategies. Her internationally recognized publications reflect a strong academic impact and translational value in pediatric and clinical neuroscience. With over 380 citations, an h-index of 10 on Scopus, and 12 on Google Scholar, her scholarly influence and commitment to impactful research are evident. As a forward-thinking clinician–scientist, she continues to advance neonatal research by integrating data-driven insights with compassionate care. Dr. Demir’s excellence, innovation, and dedication to improving neonatal health outcomes position her as a leading figure in her field and a deserving recipient of the Best Researcher Award, honoring her outstanding contributions to advancing neonatal medicine and inspiring future generations of medical scientists.

Publication Profile

Orcid

Featured Publications

Demir, S., Groteklaes, A., Dresbach, T., Müller, A., & Sabir, H. (2025, October 29). Abnormal amplitude-integrated electroencephalography and acidosis as key criteria initiating therapeutic hypothermia in asphyxiated newborns – Data from the German Hypothermia Registry. Acta Paediatrica.

EMMANUEL SCALAIS | Medicine and Health Sciences | Outstanding Scientist Award

Published on by Top Teachers

Dr.EMMANUELSCALAIS|MedicineandHealth Sciences| Outstanding Scientist Award

MD at NEPE, Luxembourg.

Dr. Emmanuel Scalais is the Chief Physician of the Pediatric Neurology Department at Centre Hospitalier de Luxembourg (CHL)He has authored 82 publications and has been cited 2,877 times in the field of pediatric neurology.His clinical expertise includes conditions such as homocystinuria, vitamin B12 deficiency anemia, and exocrine pancreatic insufficiency.

professional profiles📖

Education 🎓

Secondary School: Humanity Greco-Latine (June 1972), Collège du Sacré-Coeur, Charleroi, BelgiumHigh School: Université Catholique de LouvainBaccalauréat en Philosophie: Magna cum Laude (June 1975)Doctor of Medicine: Laude (June 1979)

work Experience💼

1988-2002: Pediatric Neurologist, CHC Espérance & Saint Vincent, Liège, Belgium (Full-time)Lecturer: Pediatric Neurology Course for nurses at “School of Sainte-Julienne,” LiègeLecturer: “Medical Approach of Handicap” in Orthopédagogie2003-2024: Pediatric Neurologist, Centre Hospitalier de Luxembourg, Department of Pediatrics (Full-time)Head of Pediatric Neurology Division (2014-2018, 2018-2024)Lecturer: Pediatric Neurology Course for nurses at “Lycée Technique pour Professions de Santé” (2006-2024)

Research Focus

Dr. Scalais has authored numerous peer-reviewed articles, with a focus on pediatric neurology, metabolic disorders, and neonatal brain function. Notable contributions include:Research on phenobarbital’s effects on cerebral blood flow in newbornsStudies on very long-chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant deathInvestigations into early myoclonic epilepsy linked to CoQ10 deficiencyDiagnostic and prognostic value of evoked potentials in neonatal hypoxiaCase studies on mitochondrial disorders, such as Leigh’s encephalopathy and POLG mutationsHydroxocobalamin dose intensification in early-onset cobalamin metabolism defects

Conclusion

Dr. Scalais based on his , , and . While increasing could further strengthen his profile, his current body of work already demonstrates and .is highly suitable for this awardsignificant contributions to pediatric neurology researchclinical impactinternational collaborationshigh-impact publications, principal investigator roles, and research fundingoutstanding scientific meritlong-term dedication to pediatric neurology

📚Publications to Noted

  • Scalais E, Beharry K, Papageorgiou A, Bureau M, Aranda JV (1992). Effects of phenobarbital on cerebral blood flow in the newborn piglet. Developmental Pharmacology and Therapeutics, 19(1), 10-18. [doi: 10.1159/000457457]

  • Scalais E, Bottu J, Wanders RJ, Ferdinandusse S, Waterham HR, De Meirleir L (2015). Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis. American Journal of Medical Genetics Part A, 167A(1), 211-214. [doi: 10.1002/ajmg.a.36803]

  • Scalais E, Chafai R, Van Coster R, Bindl L, Nuttin C, Panagiotaraki C, Seneca S, Lissens W, Ribes A, Geers C, Smet J, De Meirleir L (2013). Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2). European Journal of Paediatric Neurology, 17(6), 625-630. [doi: 10.1016/j.ejpn.2013.05.013]

  • Scalais E, Connerotte AC, Despontin K, Biver A, Ceuterick-de Groote C, Alders M, Kolivras A, Hachem JP, De Meirleir L (2016). Shwachman-Diamond syndrome presenting with early ichthyosis, associated dermal and epidermal intracellular lipid droplets, hypoglycemia, and later distinctive clinical SDS phenotype. American Journal of Medical Genetics Part A, 170(7), 1799-1805. [doi: 10.1002/ajmg.a.37673]

  • Scalais E, Francois A, Nuttin C (1996). [Diagnostic and prognostic value of evoked potentials facing cerebral hypoxia in newborn infants]. Archives de Pédiatrie, 3 Suppl 1, 251s-253s. [doi: 10.1016/0929-693x(96)86058-1]

  • Scalais E, Francois B, Schlesser P, Stevens R, Nuttin C, Martin JJ, Van Coster R, Seneca S, Roels F, Van Goethem G, Lofgren A, De Meirleir L (2012). Polymerase gamma deficiency (POLG): clinical course in a child with a two-stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh’s encephalopathy. European Journal of Paediatric Neurology, 16(5), 542-548. [doi: 10.1016/j.ejpn.2012.01.013]

  • Scalais E, Francois-Adant A, Nuttin C, Bachy A, Guerit JM (1998). Multimodality evoked potentials as a prognostic tool in term asphyxiated newborns. Electroencephalography and Clinical Neurophysiology, 108(2), 199-207. [doi: 10.1016/s0168-5597(97)00076-2]

  • Scalais E, Geron C, Pierron C, Cardillo S, Schlesser V, Mataigne F, Borde P, Regal L (2023). Would early versus late hydroxocobalamin dose intensification treatment prevent cognitive decline, macular degeneration and ocular disease in 5 patients with early-onset cblC deficiency? Molecular Genetics and Metabolism, 140(3), 107681. [doi: 10.1016/j.ymgme.2023.107681]

  • Scalais E, Nuttin C, Seneca S, Smet J, De Paepe B, Martin JJ, Stevens R, Pierart F, Battisti O, Lissens W, De Meirleir L, Van Coster R (2007). Infantile presentation of the mitochondrial A8344G mutation. European Journal of Neurology, 14(11), e3-5. [doi: 10.1111/j.1468-1331.2007.01926.x]

  • Scalais E, Osterheld E, Geron C, Pierron C, Chafai R, Schlesser V, Borde P, Regal L, Laeremans H, van Gassen KLI, van den Heuvel LPWJ, De Meirleir L (Under revision). Parenteral Hydroxocobalamin Dose Intensification in 5 Patients with Different Types of Early Onset Intracellular Cobalamin Defects: Clinical and Biochemical Responses. Journal of Inherited Metabolic Disease.